UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth
Over-High Hurdles Could Prevent Innovation From Flourishing
Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.
